| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.06 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.075 | 0.06 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.061 | 0.06 |